Electric Pulsed Brain Implants

Inner Cosmos Unveils a New Brain Computer Interface Design

Inner Cosmos introduces a new BCI, which is a brain-computer interface that was first unveiled last year in September. The neurotechnology company highlights the Digital Pill, which is a new brain implant that is designed to help treat depression using small electric pulses once it has been successfully inserted into the skull of a patient.

Now that it is running its second trial, the Digital Pill is about the size of a penny and sends pulses to the left dorsolateral prefrontal cortex between times of 15 minutes. The pill also helps with monitoring neuronal activity to help understand how much stimulation should be given to the patient's brain. The hardware rests under the skin and is non-invasively positioned on the skull as reported by Forbes.

Image Credit: Inner Cosmos

Neurotechnology Advancement
Inner Cosmos' Digital Pill brain implant introduces new avenues for neurotechnology advancements in treating depression.
Brain-computer Interface (BCI)
Inner Cosmos' Digital Pill brain implant highlights the development of BCI technology for monitoring neuronal activity and administering electric pulses for treatment.
Non-invasive Medical Devices
Inner Cosmos' Digital Pill brain implant showcases the potential for non-invasive medical devices that are positioned on the skull for treatment and monitoring neuronal activity to treat depression.

Who This Affects Most

Medical Devices
Inner Cosmos' Digital Pill brain implant is an innovative medical device that demonstrates the possibilities for non-invasive treatment of depression through neurotechnology advancements
Neuroscience
Inner Cosmos' Digital Pill brain implant is a promising development in the neuroscience industry for the treatment of depression and for further research into brain-computer interface technology.
Pharmaceuticals
Inner Cosmos' Digital Pill brain implant may disrupt the pharmaceutical industry by providing new methods for treating depression and other mental illnesses that do not rely solely on medication.
SCORE
4.0 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America, South America, Europe, Asia, Africa
GENERATION
  • Gen Alpha
  • Gen Z (primary audience)
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 43%
Activity 63%
Freshness 15%